It was known that some available markers for bladder cancer diagnosis mainly contained BTA Stat, BTA Trak, NMP22,6 Bladder Check, the ImmunoCyt test, UroVysion test, BLCA‐4, Survivin, and Microsatellite; however, their application to clinical practice still has many limitations due to their high false‐positive rate for high‐stage bladder cancer verification. Here, BIRC5 is linked to urinary bladder carcinoma.